| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000013904 |
| Receipt No. | R000016211 |
| Official scientific title of the study | Examination of sedative effects of dexmedetomidine during chronic subdural hematoma surgery under local anesthesia: prospective randomized control trial |
| Date of disclosure of the study information | 2014/05/09 |
| Last modified on | 2016/06/12 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Examination of sedative effects of dexmedetomidine during chronic subdural hematoma surgery under local anesthesia: prospective randomized control trial | |
| Title of the study (Brief title) | Sedative effects of dexmedetomidine during chronic subdural hematoma surgery under local anesthesia | |
| Region |
|
|
| Condition | |||
| Condition | Chronic subdural hematoma patient | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Efficacy of dexmedetomidine versus propofol when used for intraoperative sedation |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Efficancy and side effects of dexmedetomidine versus propofol when used for intraoperative sedation under local anesthesia |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Dexmedetomidine for intraoperative sedation | |
| Interventions/Control_2 | Propofol for intraoperative sedation | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Chronic subdural hematoma patient undergoing surgery under local anesthesia | |||
| Key exclusion criteria | Patient with liver, renal dysfunction or arrhythmia | |||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Yuko Kondo |
| Organization | Nihon University School of Medicine |
| Division name | Division of Anesthesiology, Department of Anesthesiology |
| Address | 30-1, Oyaguchi-Kamicho, Itabashi-ku, Tokyo, Japan |
| TEL | 03-3972-8111 |
| kondo.yuko@nihon-u.ac.jp | |
| Public contact | |
| Name of contact person | Yuko Kondo |
| Organization | Nihon University School of Medicine |
| Division name | Division of Anesthesiology, Department of Anesthesiology |
| Address | 30-1, Oyaguchi-Kamicho, Itabashi-ku, Tokyo, Japan |
| TEL | 03-3972-8111 |
| Homepage URL | |
| kondo.yuko@nihon-u.ac.jp | |
| Sponsor | |
| Institute | Nihon University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016211 |